The development of our brains from prenatal to postnatal stages is influenced by a complex interplay of chemicals and neural pathways, similar to the evolution of a miniature universe. However, this intricate process can give rise to debilitating conditions, such as obsessive-compulsive disorder (OCD) and chronic tic disorders (CTDs), including Tourette disorder, which impacts up to 2% of the population.
Until recently, knowledge regarding the biological underpinnings of these highly heritable disorders was limited, with only four “high-confidence” genes identified. However, new research has expanded this understanding significantly, identifying 36 genes that increase the risk of developing OCD and CTDs.
This study not only broadens the list of shared risk genes but also establishes biological links to autism and schizophrenia, while illuminating the brain circuits responsible for impulse control, movement, and habit formation, according to Gary Heiman, a genetic epidemiologist.
Published in Nature Neuroscience, researchers based at Rutgers University analyzed genetic data from nearly 4,000 individuals affected by OCD and CTD. This included over 2,400 parent-child trios and more than 1,500 singletons, nearly doubling previous sample sizes.
The research revealed that 50% of individuals with CTDs also exhibit OCD behaviors, while 30% of those with OCD have a history of tics. Utilizing brain maps from various species, researchers developed a neural blueprint that emphasizes the cortico-striato-thalamo-cortical circuit’s dysfunction in these conditions.
Key brain regions showed increased expression of risk genes during prenatal and postnatal stages, including the cortex (responsible for thinking and memory), striatum (decision-making and motivation), and thalamus (signal processing). Additionally, the cerebellum, which manages movement coordination, also exhibited high risk gene expression.
The team identified telencephalic projecting excitatory neurons as crucial for signaling and communication across brain regions, demonstrating complex interactions between genes and neural pathways. This research confirms substantial genetic overlap between OCD and CTD, reinforcing connections with other neurodevelopmental disorders, yet showed no overlap with congenital heart disease.
Heiman emphasized the importance of the long-term commitment from families who provided DNA samples over 20 years ago, allowing for valuable insights with today’s advanced sequencing technologies. The goal is to leverage these findings for better-targeted treatments based on genetic or brain pathways.
Overall, this study significantly expands our understanding of risk genes associated with OCD and CTDs, highlighting over 30 potential therapeutic targets, enhancing the prospects for effective treatments in the future.
